Business
TIME Names GeneDx CEO Katherine Stueland to the 2026 TIME100 Health List of the World’s Most Influential Leaders in Health
GAITHERSBURG, Md., February 11, 2026--TIME Names GeneDx CEO Katherine Stueland to the 2026 TIME100 Health List
About this update from Genedx Holdings Corp.
[{"type":"image","alt":"TIME Names GeneDx CEO Katherine Stueland to the 2026 TIME100 Health List of the World’s Most Influential Leaders in Health","displaySize":"","headline":null,"caption":"TIME Names GeneDx CEO Katherine Stueland to the 2026 TIME100 Health List of the World’s Most Influential Leaders in Health","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":384,"height":480,"url":"https://media.zenfs.com/en/business-wire.com/1583e158ec3f7fdafbf3eee9942ca6b7"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/JaFEkM983S6RlBIxAbm5HQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTcwNTtoPTg4MTtjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/1583e158ec3f7fdafbf3eee9942ca6b7","width":384,"height":480}},"lazy":false},{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":1200,"height":417,"url":"https://media.zenfs.com/en/business-wire.com/640d0b55254593bb06356f0dc99e658d"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/HQPj1jFCG47V93NZE37wXw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTMzNDtjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/640d0b55254593bb06356f0dc99e658d","width":960,"height":334},"lightbox":{"url":"https://s.yimg.com/ny/api/res/1.2/aRYKZ5miC46T7eJ0OY810Q--/YXBwaWQ9aGlnaGxhbmRlcjt3PTI0MDA7aD04MzQ7Y2Y9d2VicA--/https://media.zenfs.com/en/business-wire.com/640d0b55254593bb06356f0dc99e658d","width":1200,"height":417}}},{"type":"text","content":"Recognition highlights growing global impact of rare disease diagnosis and the role of genomics in transforming health outcomes","length":127,"tagName":"p","attribs":{}},{"type":"text","content":"GAITHERSBURG, Md., February 11, 2026--(BUSINESS WIRE)--GeneDx (Nasdaq: WGS), the leader in rare disease diagnosis and improving health through the power of genomic data, today announced that its President and Chief Executive Officer Katherine Stueland has been named to the TIME100 Health 2026 list – TIME’s annual recognition of the 100 individuals who most influenced global health over the past year.","length":403,"tagName":"p"},{"type":"text","content":"The recognition comes during Rare Disease Month and underscores the growing global acknowledgment of rare disease as a public health priority, as well as the critical role of genomics in accelerating diagnosis, advancing disc...